Harvard Bioscience, Inc. (HBIO)
8.09
-0.22
(-2.65%)
USD |
NASDAQ |
Oct 16, 16:00
8.09
0.00 (0.00%)
After-Hours: 16:17
Harvard Bioscience Research and Development Expense (Quarterly) : 2.453M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.453M |
| March 31, 2026 | 2.326M |
| December 31, 2025 | 2.183M |
| September 30, 2025 | 2.132M |
| June 30, 2025 | 2.189M |
| March 31, 2025 | 2.321M |
| December 31, 2024 | 2.328M |
| September 30, 2024 | 2.567M |
| June 30, 2024 | 2.626M |
| March 31, 2024 | 2.885M |
| December 31, 2023 | 3.15M |
| September 30, 2023 | 2.76M |
| June 30, 2023 | 2.957M |
| March 31, 2023 | 2.897M |
| December 31, 2022 | 2.849M |
| September 30, 2022 | 2.763M |
| June 30, 2022 | 3.497M |
| March 31, 2022 | 3.22M |
| December 31, 2021 | 2.951M |
| September 30, 2021 | 2.66M |
| June 30, 2021 | 2.701M |
| March 31, 2021 | 2.487M |
| December 31, 2020 | 2.349M |
| September 30, 2020 | 1.949M |
| June 30, 2020 | 1.897M |
| Date | Value |
|---|---|
| March 31, 2020 | 2.49M |
| December 31, 2019 | 2.645M |
| September 30, 2019 | 2.564M |
| June 30, 2019 | 2.771M |
| March 31, 2019 | 2.735M |
| December 31, 2018 | 3.045M |
| September 30, 2018 | 2.783M |
| June 30, 2018 | 2.758M |
| March 31, 2018 | 2.402M |
| December 31, 2017 | 1.526M |
| September 30, 2017 | 1.538M |
| June 30, 2017 | 1.296M |
| March 31, 2017 | 1.285M |
| December 31, 2016 | 1.156M |
| September 30, 2016 | 1.309M |
| June 30, 2016 | 1.502M |
| March 31, 2016 | 1.425M |
| December 31, 2015 | 1.532M |
| September 30, 2015 | 1.426M |
| June 30, 2015 | 1.714M |
| March 31, 2015 | 1.748M |
| December 31, 2014 | 1.564M |
| September 30, 2014 | 1.059M |
| June 30, 2014 | 1.284M |
| March 31, 2014 | 0.973M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 120.00M |
| Bio-Rad Laboratories, Inc. | 61.20M |
| Bruker Corp. | 94.30M |
| Danaher Corp. | 412.00M |
| Illumina, Inc. | 257.00M |